TABLE 4.

Use of maintenance immunosuppressive agents, targeted therapies, and immunomodulatory agents during admission

Factor	Non-SOT	SOT	p
Prednisone	111 (4.6%)	27 (60.0%)	<.001
Methylprednisolone	111 (4.6%)	3 (6.7%)	.46
Hydrocortisone	66 (2.7%)	2 (4.4%)	.35
Dexamethasone	283 (11.7%)	6 (13.3%)	.64
Tacrolimus	0 (<1%)	38 (84.4%)	<.001
Mycophenolate mofetil	8 (0.3%)	6 (13.3%)	<.001
Tocilizumab	88 (3.6%)	6 (13.3%)	.006
Remdesivir	342 (14.2%)	8 (17.8%)	.52
Hydroxychloroquine	395 (16.3%)	13 (28.9%)	.040